Real-time hemodialyzer performance using the Sweeney counter-current equation. Vary KoA, blood flow Q_b, dialysate flow Q_d, treatment time and body water volume to see clearance K, Kt/V, URR and post-dialysis BUN instantly, and check the prescription against NKF-K/DOQI adequacy targets (Kt/V >= 1.2).
Parameters
Dialyzer KoA
mL/min
Mass-transfer-area coefficient. Listed on the dialyzer spec sheet
Blood flow Q_b
mL/min
Blood-pump flow. Typical Japan 180-250, Western 350-450
Dialysate flow Q_d
mL/min
Standard is 500 mL/min. Roughly 1.5-2 times Q_b is economical
Treatment time t
hr
Standard maintenance is 4 h x 3 sessions / week
Body water V_d
L
Urea distribution volume = body weight x 0.55-0.60 (adult male ~42 L)
Pre-dialysis BUN
mg/dL
Blood urea nitrogen before treatment. Typical maintenance value 60-120
The top red band is the blood compartment; the bottom blue band is the dialysate compartment flowing in the opposite direction (counter-current). Urea particles (yellow) diffuse across the semipermeable membrane from blood to dialysate.
Counter-current clearance (Sweeney/Henderson) and the Kt/V dialysis-dose index. Q_b: blood flow, Q_d: dialysate flow, K_oA: mass-transfer-area coefficient, V_d: urea distribution volume (approximately total body water). When Q_b=Q_d, use the limit form K=Q_b·K_oA/(Q_b+K_oA).
Urea Reduction Ratio (URR) and post-dialysis BUN. In single-pool urea kinetics the urea concentration decays exponentially during the session. NKF-K/DOQI targets: Kt/V >= 1.2 and URR >= 65%.
Hemodialyzer Clearance
🙋
People say a dialysis machine works "like a kidney" — but what actually happens inside the device?
🎓
It is simpler than you'd think. The main part is a dialyzer — a cartridge holding several thousand to ten thousand thin hollow fibers, like a bundle of microscopic straws. The patient's blood flows inside the fibers and dialysate flows on the outside in the opposite direction. The fiber wall is a semipermeable membrane, so small toxins like urea and creatinine simply diffuse from the blood into the dialysate. A real kidney filters through the glomerulus; this device replaces that with engineering-grade diffusion.
🙋
So what is the difference between "KoA" and "clearance"? They both sound like performance numbers.
🎓
KoA is the raw datasheet spec: the overall mass-transfer coefficient Ko multiplied by the membrane area A — the dialyzer's theoretical ceiling. Clearance K is the operational result: how many mL/min of blood you actually cleaned at the chosen flows. With the same KoA, raising Q_b lifts K — but it saturates. That's exactly what the Sweeney equation predicts, and you can see it in the top chart on the right: K rises with Q_b, then bends over toward a horizontal asymptote.
🙋
I read that Japan typically uses Q_b around 200 mL/min while the U.S. runs 400 or more. Why such a big difference?
🎓
Good catch. In theory the U.S. approach with higher Q_b reaches the same K faster, but it loads the patient's vascular access (the arteriovenous shunt) much harder. Japan tends to favor "long treatments, low flow, low stress" for long-term survival, while the U.S. favors "short, high-flow, fast social return." Interestingly both arrive at Kt/V around 1.4 — they just trade Q_b against t. Move the time slider and you'll see Kt/V rise linearly with t at fixed K.
🙋
Where does the magic number "Kt/V >= 1.2" come from? And why divide by body weight?
🎓
You don't divide by body weight directly — you divide by V, the urea distribution volume (roughly 42 L for an adult male). K·t is the total blood volume cleaned; V is the patient's body-water reservoir. So Kt/V says "how many times we cleaned the whole body water." Large clinical trials in the 1990s (notably the HEMO Study) showed mortality climbs sharply when Kt/V drops below 1.2, so NKF-K/DOQI fixed the minimum at 1.2 and the target at 1.4. It's probably the most thoroughly validated engineering metric in clinical medicine.
🙋
Is there ever a downside to making Kt/V too large?
🎓
Yes. Removing urea too fast creates an osmotic gradient across brain cells and can trigger "dialysis disequilibrium syndrome" — headache, nausea, even seizures. For first-time patients the team deliberately starts low (Kt/V around 0.8-1.0) and builds up. Also, Kt/V is a small-molecule metric (urea) and says nothing about middle molecules like β2-microglobulin, which can only be removed by convection (hemodiafiltration / HDF). Modern dialysis is "Kt/V for small molecules + online HDF for middle molecules" as a pair.
Frequently Asked Questions
KoA is the overall mass-transfer-area coefficient (Ko times the membrane area A) and represents the theoretical maximum clearance capacity of a dialyzer in mL/min. The spec sheet lists it per solute, e.g. "urea KoA" or "creatinine KoA". Conventional hollow-fiber dialyzers have urea KoA of 500-1500 mL/min, while high-performance membranes reach 1500-2500 mL/min. A larger KoA gives more headroom for clearance K to grow when you raise Q_b and Q_d.
Kt/V is the dimensionless ratio "clearance times treatment time divided by body water volume" — how many times the patient's urea distribution volume was cleaned in one session. NKF-K/DOQI recommends Kt/V >= 1.2 (target 1.4) for three-times-weekly hemodialysis. Large clinical trials such as HEMO showed that mortality rises markedly when Kt/V falls below 1.2. Below 1.0 is clearly inadequate; 1.0-1.2 is the borderline zone.
Q_b (blood flow) is much more effective. Clearance K saturates near Q_b, so the standard approach is to raise Q_b first and keep Q_d at 1.5-2 times Q_b. With KoA=800 and Q_d=500, increasing Q_b from 200 to 300 raises K from about 175 to 248 (+73 mL/min), but holding Q_b=300 and pushing Q_d from 500 to 800 only nudges K from 248 to 269 (+21). Note that very high Q_b loads the vascular access and increases blood-side pressure drop, so each patient has a practical ceiling.
URR (Urea Reduction Ratio) is (pre-BUN minus post-BUN) divided by pre-BUN times 100% — a simple bedside metric needing only two blood draws. Kt/V is a model-derived value (single-pool urea kinetics) that also accounts for fluid removal and urea rebound. They are linked by URR ≈ 1 - exp(-Kt/V): Kt/V=1.2 corresponds to URR around 70%, and Kt/V=1.4 to URR around 75%. NKF treats URR >= 65% as the minimum acceptable target.
Real-world Applications
Maintenance hemodialysis clinic dialyzer selection: Worldwide, millions of patients undergo three-times-weekly, 4-hour hemodialysis. Clinics match the dialyzer KoA grade to each patient's body size (V) and vascular-access capacity (Q_b ceiling). Pre-calculating Kt/V with a tool like this lets the team pick the right dialyzer class — small (KoA ≈ 500), mid (≈ 800) or large (≈ 1200) — without over-spending on oversized cartridges while still securing Kt/V >= 1.4.
ICU acute kidney injury and CRRT design: In intensive-care units, hemodynamically unstable acute-kidney-injury patients receive CRRT (continuous renal replacement therapy) for 24 hours per day. Q_b is kept low (100-200 mL/min) and Kt/V is tracked as a daily integral. This tool lets the team predict Kt/V at extended treatment times and engineer a low-flow, long-duration prescription that still matches conventional intermittent hemodialysis on a weekly basis.
R&D evaluation of new dialyzer membranes: Membrane manufacturers measure KoA on prototype materials (polysulfone, polyethersulfone, PMMA and so on) in vitro and then feed those values into the Sweeney equation to predict clinical clearance. This "desktop screening" is a standard preclinical step that drives optimization of hollow-fiber count and membrane area before any patient is enrolled.
Patient education and shared decision making: Many dialysis patients want to understand "how well my treatment is working" in concrete numbers. Nurses and clinical engineers can use an interactive tool like this to show a patient "your Kt/V today is 1.42, above the recommended target" — supporting adherence, reinforcing why salt, fluid and potassium limits matter, and turning an abstract therapy into a tangible engineering result.
Common Misconceptions and Caveats
The biggest pitfall is "using the catalog KoA as the design value". The spec sheet KoA is measured on a brand-new dialyzer under ideal conditions (uniform flow distribution, no air pockets, no protein fouling). In the clinic the effective KoA typically drops to 70-85% of the rated value because (1) albumin and β2-microglobulin adsorb onto the membrane within the first 30 minutes, reducing effective surface area, (2) blood distribution across the fiber bundle is rarely uniform, and (3) reused dialyzers accumulate bleach-induced degradation. When sizing a prescription, applying a 0.8 safety factor to the catalog KoA usually brings predictions in line with measured clearance.
Second, "assuming Kt/V alone defines an adequate prescription" is dangerous. Kt/V is specific to urea (MW 60) and tells you nothing about middle molecules like β2-microglobulin (MW 11,800). Middle molecules need convection — ultrafiltration — to come out, and even when Kt/V looks fine a patient can develop dialysis-related amyloidosis or carpal-tunnel syndrome from poor middle-molecule clearance. Modern dialysis is a two-pronged design: "small molecules by Kt/V + middle molecules by online HDF (hemodiafiltration)". This tool focuses on the first pillar; remember the second exists.
Finally, the "trim time, boost flow" trap. The same Kt/V=1.4 reached at Q_b=400 in 3 h is not clinically equivalent to Q_b=200 in 4.5 h; the longer treatment generally yields better outcomes. Reasons: (1) short, high-flow sessions raise the ultrafiltration rate (UFR), promoting intradialytic hypotension, (2) longer treatments remove middle molecules, phosphate and potassium more effectively, and (3) urea rebound — redistribution from cells — is larger in short sessions, so the effective Kt/V is lower than the equilibrated value. Don't read Kt/V as a single scalar; weigh Q_b, t, blood-pressure tolerance and nutrition together.
How to Use
Enter hemodialyzer KoA (mL/min) — typical values range 600–1200 for high-flux dialyzers; 400–700 for low-flux models.
Set blood flow rate Q_b (mL/min): standard clinical range 300–450 mL/min; higher flows improve solute clearance.
Input dialysate flow Q_d (mL/min): typically 500–800 mL/min; flows above 800 show diminishing returns due to mass transfer limitations.
Specify treatment time (minutes): standard thrice-weekly dialysis uses 240 min sessions; twice-weekly uses 180 min for maintenance patients.
Simulator applies Sweeney counter-current equation to compute clearance K, Kt/V adequacy index, and urea reduction ratio (URR).
Recirculation >5% (typical fistula access) reduces effective clearance by 3–8%; simulator uses delivered clearance assumption — multiply K by (1 − recirculation fraction) for access cardiology adjustments.
Ultrafiltration >1.5 L/hour causes hemoconcentration and blood viscosity rise, reducing effective KoA by 5–12%; account for patient dry weight targets (e.g., 2–3 kg removal over 240 min).
Urea rebound occurs 30 min post-dialysis; Kt/V underestimated by 5–8% if measured immediately; clinical labs typically sample 30–60 min post-treatment for true equilibrated Kt/V.
Phosphorus (MW 95 Da) and beta-2 microglobulin (11,800 Da) clear differently; simulator focuses urea kinetics; supplement with phosphate binder protocols for larger solutes.